BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 29080923)

  • 1. Treatment of critical-sized bone defects: clinical and tissue engineering perspectives.
    Roddy E; DeBaun MR; Daoud-Gray A; Yang YP; Gardner MJ
    Eur J Orthop Surg Traumatol; 2018 Apr; 28(3):351-362. PubMed ID: 29080923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of non-unions with bone defects: which option and why?
    Ashman O; Phillips AM
    Injury; 2013 Jan; 44 Suppl 1():S43-5. PubMed ID: 23351870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Critical Bone Defects.
    Marecek GS; Little MT; Gardner MJ; Stevanovic M; Lefebvre R; Bernstein M
    Instr Course Lect; 2020; 69():417-432. PubMed ID: 32017743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Bone Defects in Orthopedic Trauma.
    Gage J; Liporace A; Egol A; McLaurin M
    Bull Hosp Jt Dis (2013); 2018 Mar; 76(1):4-8. PubMed ID: 29537950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Systematic Review of Clinical Studies Investigating Mesenchymal Stem Cells for Fracture Non-Union and Bone Defects.
    Killington K; Mafi R; Mafi P; Khan WS
    Curr Stem Cell Res Ther; 2018; 13(4):284-291. PubMed ID: 28914208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bone tissue engineering for bone defect therapy].
    Boos AM; Arkudas A; Kneser U; Horch RE; Beier JP
    Handchir Mikrochir Plast Chir; 2010 Dec; 42(6):360-8. PubMed ID: 20821364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shortening and Angulation Strategies to Address Composite Bone and Soft Tissue Defects.
    Pierrie SN; Hsu JR
    J Orthop Trauma; 2017 Oct; 31 Suppl 5():S32-S35. PubMed ID: 28938389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study on the role of gelatin, chitosan and their combination as tissue engineered scaffolds on healing and regeneration of critical sized bone defects: an in vivo study.
    Oryan A; Alidadi S; Bigham-Sadegh A; Moshiri A
    J Mater Sci Mater Med; 2016 Oct; 27(10):155. PubMed ID: 27590825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of mesenchymal stem cells delivered via hydrogel-based tissue engineered periosteum on bone allograft healing.
    Hoffman MD; Xie C; Zhang X; Benoit DS
    Biomaterials; 2013 Nov; 34(35):8887-98. PubMed ID: 23958029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-bone critical-size defects treated with tissue-engineered grafts: a study on sheep.
    Viateau V; Guillemin G; Bousson V; Oudina K; Hannouche D; Sedel L; Logeart-Avramoglou D; Petite H
    J Orthop Res; 2007 Jun; 25(6):741-9. PubMed ID: 17318898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scaffolds combined with stem cells and growth factors in healing of pseudotumoral lesions of bone.
    De Biase P; Campanacci DA; Beltrami G; Scoccianti G; Ciampalini L; Pecchioli O; Capanna R
    Int J Immunopathol Pharmacol; 2011; 24(1 Suppl 2):11-5. PubMed ID: 21669131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Possibilities in the reconstruction of bone defects].
    Baumgart R; Betz A; Kessler S; Kettler M; Schweiberer L
    Orthopade; 1994 Nov; 23(6):396-403. PubMed ID: 7831053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone regeneration and fracture healing. Experience with distraction osteogenesis model.
    Richards M; Goulet JA; Weiss JA; Waanders NA; Schaffler MB; Goldstein SA
    Clin Orthop Relat Res; 1998 Oct; (355 Suppl):S191-204. PubMed ID: 9917639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone substitutes, growth factors and distraction osteogenesis].
    Nienhuijs ME; Meijer GJ; Merkx MA; Walboomers XF; Jansen JA
    Ned Tijdschr Tandheelkd; 2008 Jun; 115(6):297-304. PubMed ID: 18618983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modern concepts in mandibular reconstruction in oral and oropharyngeal cancer.
    Wang KH; Inman JC; Hayden RE
    Curr Opin Otolaryngol Head Neck Surg; 2011 Apr; 19(2):119-24. PubMed ID: 21358547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scaffolds for bone healing: concepts, materials and evidence.
    Lichte P; Pape HC; Pufe T; Kobbe P; Fischer H
    Injury; 2011 Jun; 42(6):569-73. PubMed ID: 21489531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological aspects of segmental bone defects management.
    Dumic-Cule I; Pecina M; Jelic M; Jankolija M; Popek I; Grgurevic L; Vukicevic S
    Int Orthop; 2015 May; 39(5):1005-11. PubMed ID: 25772279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of bone-graft substitutes in large bone defects: any specific needs?
    Calori GM; Mazza E; Colombo M; Ripamonti C
    Injury; 2011 Sep; 42 Suppl 2():S56-63. PubMed ID: 21752369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone regeneration strategies: current trends but what the future holds?
    Giannoudis PV; Calori GM; Begue T; Schmidmaier G
    Injury; 2013 Jan; 44 Suppl 1():S1-2. PubMed ID: 23351862
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone tissue engineering in the greater omentum is enhanced by a periosteal transplant in a miniature pig model.
    Naujokat H; Lipp M; Açil Y; Wieker H; Birkenfeld F; Sengebusch A; Böhrnsen F; Wiltfang J
    Regen Med; 2019 Feb; 14(2):127-138. PubMed ID: 30764722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.